[go: up one dir, main page]

GB201305103D0 - An oral dosage form - Google Patents

An oral dosage form

Info

Publication number
GB201305103D0
GB201305103D0 GB201305103A GB201305103A GB201305103D0 GB 201305103 D0 GB201305103 D0 GB 201305103D0 GB 201305103 A GB201305103 A GB 201305103A GB 201305103 A GB201305103 A GB 201305103A GB 201305103 D0 GB201305103 D0 GB 201305103D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
oral dosage
oral
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201305103A
Other versions
GB2512098A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB1305103.2A priority Critical patent/GB2512098A/en
Publication of GB201305103D0 publication Critical patent/GB201305103D0/en
Priority to PCT/GB2014/050792 priority patent/WO2014147377A1/en
Publication of GB2512098A publication Critical patent/GB2512098A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1305103.2A 2013-03-20 2013-03-20 An oral dosage form Withdrawn GB2512098A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1305103.2A GB2512098A (en) 2013-03-20 2013-03-20 An oral dosage form
PCT/GB2014/050792 WO2014147377A1 (en) 2013-03-20 2014-03-14 An oral dosage form having an outer surface comprising a medicated print

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1305103.2A GB2512098A (en) 2013-03-20 2013-03-20 An oral dosage form

Publications (2)

Publication Number Publication Date
GB201305103D0 true GB201305103D0 (en) 2013-05-01
GB2512098A GB2512098A (en) 2014-09-24

Family

ID=48226736

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1305103.2A Withdrawn GB2512098A (en) 2013-03-20 2013-03-20 An oral dosage form

Country Status (2)

Country Link
GB (1) GB2512098A (en)
WO (1) WO2014147377A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898447B2 (en) 2016-10-27 2021-01-26 Psirrros Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
RU2674692C2 (en) * 2016-10-27 2018-12-12 Общество с ограниченной ответственностью "Инжиниринговый сервис и консалтинг" Ready medical form with possibility of individual dosing of medicine, method of its manufacture and application
CN113874000A (en) * 2019-04-22 2021-12-31 尼普洛株式会社 Method for producing pharmaceutical preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849494A1 (en) * 1978-11-15 1980-05-29 Voss Gunter M METHOD FOR THE PRODUCTION OF MEDICINAL FORMS
GB2074947B (en) * 1980-04-23 1984-10-10 Thomae Gmbh Dr K Printing on pharmaceutical mouldings tablets or coated tablets
DE19940241A1 (en) * 1999-08-25 2001-03-01 Lohmann Therapie Syst Lts Method for applying at least one active substance to a thin substrate forming a carrier layer involves use of liquid active substances which are applicable by bubble jet printing techniques
US20040219109A1 (en) * 2003-03-10 2004-11-04 Hatch Edwin Burton Printing identification of incorporated medications onto medicated chewing gums, medicated candies, and other medicated edible products
US20040253185A1 (en) * 2003-06-12 2004-12-16 Atrium Medical Corp. Medicated ink
US8080097B2 (en) * 2003-11-06 2011-12-20 Hewlett-Packard Development Company, L.P. System and a method for the creation of edible, optically invisible images
JP2008522970A (en) * 2004-12-06 2008-07-03 レリアント ファーマスーティカルズ インコーポレイテッド Omega-3 fatty acids and dyslipidemic agents for lipid therapy
CA2600429A1 (en) * 2005-03-08 2006-09-14 Reliant Pharmaceuticals, Inc. Treatment with statin and omega-3 fatty acids and a combination product thereof
WO2006099618A1 (en) * 2005-03-16 2006-09-21 Dr. Reddy's Laboratories Ltd. Delivery system for multiple drugs
EP2081550B2 (en) * 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
JP2009541433A (en) * 2006-06-26 2009-11-26 ヴァルファルマ ソチエタ アノニマ Pharmaceutical compositions for oral administration of omega polyene fatty acids, and one or more incompatible ingredients and the process of their preparation
US20080026040A1 (en) * 2006-07-31 2008-01-31 Isaac Farr Active agent-releasing dosage forms
KR101310710B1 (en) * 2011-03-23 2013-09-27 한미약품 주식회사 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
IN2014DN03370A (en) * 2011-10-28 2015-06-05 Hewlett Packard Development Co

Also Published As

Publication number Publication date
WO2014147377A1 (en) 2014-09-25
GB2512098A (en) 2014-09-24

Similar Documents

Publication Publication Date Title
IL274024A (en) Oral compositions
IL278183A (en) Proton-binding polymers for oral administration
IL246377A0 (en) Oral pharmaceutical composition
GB201306610D0 (en) Pharmaceutical compounds
IL245124A0 (en) Abuse-deterrent dosage forms
SG11201510442TA (en) Oral composition
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
IL245705A0 (en) Pharmaceutical dosage forms
PL3089593T3 (en) Advanced gum forming
GB201305103D0 (en) An oral dosage form
DK3052087T3 (en) Implantable solid dosage form
GB2520315B (en) Oral Syringes
GB201316431D0 (en) Dental Phantom
GB201320786D0 (en) Medicament
HU4880U (en) Inhalator
GB201316662D0 (en) Pharmaceutical Combination
GB201321316D0 (en) Pharmaceutical Compound
GB201315734D0 (en) Pharmaceutical compounds
GB201309405D0 (en) Pharmaceutical compound
GB201308780D0 (en) Pharmaceutical compounds
GB201308781D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)